Cytochrome P450: A Target for Drug Development for Skin Diseases
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 123 (3) , 417-425
- https://doi.org/10.1111/j.0022-202x.2004.23307.x
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Quantitative Real-Time Reverse Transcription–Polymerase Chain Reaction Analysis of Drug Metabolizing and Cytoprotective Genes in Psoriasis and Regulation by Ultraviolet RadiationJournal of Investigative Dermatology, 2003
- Human Skin is a Steroidogenic Tissue: Steroidogenic Enzymes and Cofactors Are Expressed in Epidermis, Normal Sebocytes, and an Immortalized Sebocyte Cell Line (SEB-1)Journal of Investigative Dermatology, 2003
- Expression, structure‐function, and molecular modeling of vitamin D P450sJournal of Cellular Biochemistry, 2003
- The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretinBritish Journal of Dermatology, 1998
- Evidence for Multiple Inducible Cytochrome P450 Isozymes in Sencar Mouse Skin by PyridineBiochemical and Biophysical Research Communications, 1994
- Eicosanoids in skin of patients with atopic dermatitis: Prostaglandin E and leukotriene B are present in biologically active concentrationsJournal of Allergy and Clinical Immunology, 1989
- Clotrimazole, an Inhibitor of Benzo[a]pyrene Metabolism and Its Subsequent Glucuronidation, Sulfation, and Macromolecular Binding in BALB/c Mouse Cultured KeratinocytesJournal of Investigative Dermatology, 1986
- KETOCONAZOLE FOR HIRSUTISMThe Lancet, 1985
- Induction of drug metabolising enzymes in the skin by topical steroidsThe Journal of Steroid Biochemistry and Molecular Biology, 1984
- Induction of benzo[α]pyrene hydroxylase activity in rat skinLife Sciences, 1970